Samsung Epirus Holdings announced on October 28 that its subsidiary, Samsung Bioepis, recorded third-quarter sales of 442.2 billion won and an operating profit of 132.6 billion won. These figures represent increases of 0.3% and 2.8%, respectively, compared to the same period last year.
For the third quarter of this year, Samsung Bioepis achieved cumulative sales of 1.2893 trillion won and an operating profit of 363.2 billion won, reaching 97% of last year's total operating profit of 375.9 billion won.
For the third quarter of this year, Samsung Bioepis achieved cumulative sales of 1.2893 trillion won and an operating profit of 363.2 billion won, reaching 97% of last year's total operating profit of 375.9 billion won.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.